IU Startups to be Showcased to Investors

Posted: Updated:
(Image of Teri Willey courtesy of the IURTC.) (Image of Teri Willey courtesy of the IURTC.)

Indiana University Ventures Managing Director Teri Willey will Wednesday present five companies supported by the Indiana Philanthropic Venture Fund or the Innovate Indiana Fund to a panel of investors. Wiley will showcase the companies to Midwest angel investors and venture capitalists at the Midwest Growth Capital Symposium in Michigan. 

The companies are:

  • Apexian Pharmaceuticals: Apexian is a clinical-stage biotechnology company developing therapeutic agents targeting APE1/Ref1 to treat cancer. 
  • Care Revolution: Care Revolution supports a new RN role that changes the way care is delivered to residents in nursing homes, increasing the quality of care and significantly reducing hospitalization. 
  • Confluence Pharmaceuticals: Confluence is a neuroscience company developing therapies for fragile X syndrome and autism spectrum disorder.
  • NERx Biosciences: NERx Biosciences is an early-stage biotechnology company focused on the development of drugs targeting the DNA damage response pathway. 
  • Vascugen: Vascugen is a regenerative medicine company developing allogeneic cell therapy products based on technology developed by Dr. Mervin Yoder at the IU School of Medicine. 

“We are optimistic about our investment in these companies, but even more so as we are in good company with excellent co-investors. Our philosophy has always been to syndicate, or co-invest, with other organizations to complete one or more rounds of financing,” Willey said in a news release. “Presenting these five companies at the Midwest Growth Capital Symposium could yield immediate results. It also will keep Indiana University top-of-mind with these angel investors and venture capitalists in the future.”

  • Perspectives

    • Circling Back on WeWork

      Back in July when we first discussed WeWork, this fast-growing but money-losing venture was one of the most talked-about IPOs in years. At that time, we noted that it was too early to say what would happen, but “it should be very interesting to watch it all play out.” Turns out, that was a massive understatement!



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • Photo courtesy of MutualBank

      MutualBank President Dies

      The President and Chief Operating Officer of Muncie-based MutalBank Pat Botts has died. In a statement on Facebook posted Sunday, the company said the passing was unexpected.

    • Artist rendering of proposed headquarters for Ruoff Home Mortgage in Fort Wayne.

      Ruoff to Build New HQ in Downtown Fort Wayne

      Fort Wayne-based Ruoff Home Mortgage has announced plans to build a $43 million corporate headquarters in downtown Fort Wayne. Plans call for a 110-thousand square foot, nine-story structure, at the corner of Ewing Street and Jefferson Boulevard. The building would include leasable office and retail space, as well as a parking garage. It would overlook Parkview Field, home of the Fort Wayne Tin Caps minor league baseball team. The company is currently located on...

    • Photo courtesy of Indiana Premium outlets

      Simon Announces New Name for Shopping Center

      Indianapolis-based Simon Property Group Inc. (NYSE: SPG) has announced Edinburgh Premium Outlets will become Indiana Premium Outlets. The company says extensive enhancements are currently underway to reflect the new name and are slated for completion by Holiday 2019. 

    • (image provided by Purdue University)

      'PlaneEnglish' Technology Lands U.S. Air Force Funding

      Technology intended to help young pilots learn how to better communicate with air traffic controllers has caught the attention of the United States Air Force and earned the two Purdue University graduates, who developed the software, a $50,000 federal grant. The creators of the simulator technology PlaneEnglish have been awarded a Small Business Innovation Research award. 

    • FDA Approves Lilly Migraine Drug

      The U.S. Food and Drug Administration has given another approval for a drug from Indianapolis-based Eli Lilly and Co. (NYSE: LLY). The approval of REYVOW is for the treatment of patients with acute migraines.